Association of carnitine deficiency in Indian continuous ambulatory peritoneal dialysis patients with anemia, erythropoietin use, residual renal function, and diabetes mellitus.

Association of carnitine deficiency in Indian continuous ambulatory peritoneal dialysis patients with anemia, erythropoietin use, residual renal function, and diabetes mellitus. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Association of carnitine deficiency in Indian continuous ambulatory peritoneal dialysis patients with anemia, erythropoietin use, residual renal function, and diabetes mellitus. Abstract Text:

S Ramalakshmi,Bjoe Baben,Ben S Ashok,V Jayanthi,Nancy Leslie,Georgi Abraham,S Ramalakshmi,Bjoe Baben,Ben S Ashok,V Jayanthi,Nancy Leslie,Georgi Abraham,

OBJECTIVE: In the present study, we aimed to determine levels of free carnitine in hemodialysis (HD) and peritoneal dialysis (PD) patients in India and to correlate carnitine deficiency with various clinical parameters. METHODS: Patients on HD and PD at two tertiary care centers were selected for the study. Baseline data were obtained, and a free carnitine analysis was performed. Carnitine deficiency was defined as a free carnitine level of less than 40 micromol/L. RESULTS: The total number of study patients was 96 (77 on HD, 19 on PD). In the PD group, the mean age was 56 years, with 26.3% of the patients being vegan, 47.4% having diabetes, and 57.9% having a daily urine output of <500 mL. The mean carnitine level in that group was 38.9 micromol/L, and 68.4% of the patients had a carnitine deficiency. A Pearson correlation test failed to show any association of carnitine level with parameters such as anemia, use of erythropoietin, non-vegetarian diet, diabetes, and hypertension. In the HD group, the mean age was 45 years, with 22% of the patients being vegan, 23% having diabetes, and 45.5% having a daily urine output of <500 mL. The mean carnitine level in the group was 38.2 micromol/L, and 64.3% of the patients had a carnitine deficiency. Residual renal function and duration of dialysis were different in HD patients with and without carnitine deficiency. Carnitine levels in the HD group correlated positively and statistically significantly with the presence of diabetes and hypertension. CONCLUSION: This study is the first demonstration that Indian dialysis patients have carnitine deficiency.

Association of carnitine deficiency in Indian continuous ambulatory peritoneal dialysis patients with anemia, erythropoietin use, residual renal function, and diabetes mellitus. Publishing Authors By Initials

S Ramalakshmi,B Baben,BS Ashok,V Jayanthi,N Leslie,G Abraham,S Ramalakshmi,B Baben,BS Ashok,V Jayanthi,N Leslie,G Abraham,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Association of carnitine deficiency in Indian continuous ambulatory peritoneal dialysis patients with anemia, erythropoietin use, residual renal function, and diabetes mellitus. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Peritoneal dialysis international : journal of the

VOLUME: 27 Suppl 2

Page Numbers: S235-8

Journal Abbreviation:

ISSN: 0896-8608

DAY: 8

MONTH: Jun

YEAR: 2007

Association of carnitine deficiency in Indian continuous ambulatory peritoneal dialysis patients with anemia, erythropoietin use, residual renal function, and diabetes mellitus. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8904033

Association of carnitine deficiency in Indian continuous ambulatory peritoneal dialysis patients with anemia, erythropoietin use, residual renal function, and diabetes mellitus. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Association of carnitine deficiency in Indian continuous ambulatory peritoneal dialysis patients with anemia, erythropoietin use, residual renal function, and diabetes mellitus. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Association of carnitine deficiency in Indian continuous ambulatory peritoneal dialysis patients with anemia, erythropoietin use, residual renal function, and diabetes mellitus.

AFFILIATION: Department of Nephrology, SRMC & RI, Chennai, India.

Country: Canada

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Perit Dial Int

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Association of carnitine deficiency in Indian continuous ambulatory peritoneal dialysis patients with anemia, erythropoietin use, residual renal function, and diabetes mellitus Related Publications

• 11,12-epoxyeicosatrienoic acid stimulates heme-oxygenase-1 in endothelial cells.
• A male patient with right-sided thoracic kidney, diabetes mellitus, hearing loss and renal dysfunction.
• A novel TLR4-mediated signaling pathway leading to IL-6 responses in human bladder epithelial cells.
• A survey in India of doctors' knowledge, attitudes and practice regarding telemedicine and e-health.
• Association of carnitine deficiency in Indian continuous ambulatory peritoneal dialysis patients with anemia, erythropoietin use, residual renal function, and diabetes mellitus.
• Cleavage of the C-terminal serine of human alphaA-crystallin produces alphaA1-172 with increased chaperone activity and oligomeric size.
• Cyclic AMP-regulated exocytosis of Escherichia coli from infected bladder epithelial cells.
• Effect of oxidation of alphaA- and alphaB-crystallins on their structure, oligomerization and chaperone function.
• Genetic suppression of HO-1 exacerbates renal damage: reversed by an increase in the antiapoptotic signaling pathway.
• HMGB1 and LPS induce distinct patterns of gene expression and activation in neutrophils from patients with sepsis-induced acute lung injury.
• Harboring of particulate allergens within secretory compartments by mast cells following IgE/FcepsilonRI-lipid raft-mediated phagocytosis.
• Hard metal lung disease: still hard to understand.
• Heme oxygenase-1 inhibition of Nox oxidase activation is a microvascular endothelial antioxidant effect of NO.
• Identification of a series of tetrahydroisoquinoline derivatives as potential therapeutic agents for breast cancer.
• Impact of silencing HO-2 on EC-SOD and the mitochondrial signaling pathway.
• Impaired CD8 T cell memory and CD4 T cell primary responses in IL-7R alpha mutant mice.
• Induction of heme oxygenase-1 in renovascular hypertension is associated with inhibition of apoptosis.
• Interdiction of the diabetic state in NOD mice by sustained induction of heme oxygenase: possible role of carbon monoxide and bilirubin.
• Involvement of the urokinase kringle domain in lipopolysaccharide-induced acute lung injury.
• Long-term treatment with the apolipoprotein A1 mimetic peptide increases antioxidants and vascular repair in type I diabetic rats.
• Modulation of selenite cataract by the flavonoid fraction of Emilia sonchifolia in experimental animal models.
• Protection against selenite cataract in rat lens by drevogenin D, a triterpenoid aglycone from Dregea volubilis.
• Role of arginine-163 and the 163REEK166 motif in the oligomerization of truncated alphaA-crystallins.
• Systemic sclerosis: a prototypic multisystem fibrotic disorder.
• The phosphatidylinositol 3-kinase inhibitor, PX-866, is a potent inhibitor of cancer cell motility and growth in three-dimensional cultures.
• Toll-like receptor 4 (TLR4) is required for protective immunity to larval Strongyloides stercoralis in mice.
• Up-regulation of heme oxygenase provides vascular protection in an animal model of diabetes through its antioxidant and antiapoptotic effects.
• Utility of tissue Doppler and strain echocardiography in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
• Variant IL-1 receptor-associated kinase-1 mediates increased NF-kappa B activity.
• Vascular abnormalities in primary amyloidosis.